Keyword: GW Pharmaceuticals

Cannabis

GW Pharma gains on positive pivotal data

British cannabinoid company GW Pharmaceuticals was up about 15% in early trading on news that its lead candidate, Epidiolex (cannabidiol or CBD), had positive Phase III data in the treatment of a rare and severe kind of epilepsy.